Clinical Trial Update: National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real Life

View source ↗

Summary

A national observational study assessing the real-world use of Inflectra (infliximab biosimilar) across multiple inflammatory diseases completed with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Crohn Disease
• Psoriatic Arthritis
• Rheumatoid Arthritis
• Ulcerative Colitis

Drugs mentioned

• INFLECTRA (infliximab-dyyb)

Snippet

Sponsor: Pfizer | Conditions: Crohn Disease, Ulcerative Colitis | Status: COMPLETED | Results posted: 2023-01-25